Skip to main content

OS Therapies Inc

OSTX
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001795091

No open-market purchases or sales by OS Therapies Inc insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $5.50M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding OS Therapies Inc changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of OSTX: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders1325+12
Shares603.7K1.56M+959.5K (+158.9%)
Value$1.13M$3.07M+$1.93M (+170.2%)

New holders (13)

Institutions that held OS Therapies Inc at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to OSTX in Q3 2025
InstitutionSharesValue% of portfolio
Marshall Wace, LLP198,552$389.2K0.00%
Vanguard Group Inc188,263$369.0K0.00%
Geode Capital Management, LLC187,688$367.9K0.00%
Millennium Management LLC93,574$183.4K0.00%
Two Sigma Investments, LP86,247$169.0K0.00%
Northern Trust Corp56,263$110.3K0.00%
State Street Corp50,300$98.6K0.00%
Ground Swell Capital, LLC20,462$40.1K0.09%
Mercer Global Advisors Inc20,440$40.1K0.00%
Susquehanna International Group, LLP14,961$29.3K0.00%
Sanders Morris Harris LLC12,000$23.5K0.00%
Two Sigma Securities, LLC10,237$20.1K0.00%
Jones Financial Companies LLLP7,867$16.1K0.00%

Sold out (1)

Institutions that held OS Therapies Inc at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of OSTX in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
XTX Topco Ltd33,489$63.0K